Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Maybe this will raise the bid ??

CUPERTINO, Calif. – 2 FEB 2009 -- Today Alliacense announced that the German Federal Patent Court (Bundespatentgericht, BPatG) in Munich affirmed the validity of DE 6,903,356 8T2, the German counterpart to EP 0,786,730. The affirmed German Patent and its EP counterparts cover technology utilized in a majority of microprocessor-based products manufactured and sold today. EP'730 is the European counterpart of the basic MMP Portfolio application filed in 1989, which resulted in seven issued US patents, four of which remain the subject of on-going patent suits between The TPL Group and several non-US companies

Share
New Message
Please login to post a reply